1. Home
  2. GSHD vs NEO Comparison

GSHD vs NEO Comparison

Compare GSHD & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Goosehead Insurance Inc.

GSHD

Goosehead Insurance Inc.

HOLD

Current Price

$39.59

Market Cap

891.2M

Sector

Finance

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$8.66

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GSHD
NEO
Founded
2003
2001
Country
United States
United States
Employees
1600
N/A
Industry
Specialty Insurers
Precision Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
891.2M
1.0B
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
GSHD
NEO
Price
$39.59
$8.66
Analyst Decision
Buy
Strong Buy
Analyst Count
12
8
Target Price
$72.50
$13.38
AVG Volume (30 Days)
362.8K
2.0M
Earning Date
04-22-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.04
N/A
Revenue
$365,304,000.00
N/A
Revenue This Year
$16.40
$10.63
Revenue Next Year
$18.53
$9.73
P/E Ratio
$39.67
N/A
Revenue Growth
16.15
N/A
52 Week Low
$35.84
$4.72
52 Week High
$113.00
$13.74

Technical Indicators

Market Signals
Indicator
GSHD
NEO
Relative Strength Index (RSI) 44.67 53.18
Support Level $39.99 $8.68
Resistance Level $46.40 $8.84
Average True Range (ATR) 2.32 0.41
MACD 0.04 -0.02
Stochastic Oscillator 49.41 39.14

Price Performance

Historical Comparison
GSHD
NEO

About GSHD Goosehead Insurance Inc.

Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions. The company is has a single reportable segment: insurance distribution.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: